Results 221 to 230 of about 145,570 (329)

Celiac disease in children with focus on symptoms and quality of life. [PDF]

Sci Rep
Perez-Junkera G, Lasa A, Delgado-Sanzonetti L, Lekuona Serrano A, Vázquez-Polo M, Churruca I, Navarro V, Larretxi I.   +7 more
europepmc   +1 more source

New cases expand the genotype, phenotype and therapeutic landscape of H syndrome

British Journal of Haematology, EarlyView.
Clément Triaille, Julie Beauchemin, Philippe M. Campeau, Hugo Chapdelaine, Julie Dery, Maria Kondyli, Grant Mitchell, Julie Powell, Sophie Turpin, Guilhem Cros, Fabien Touzot   +10 more
wiley   +1 more source

The exposomal imprint on rosacea: More than skin deep

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Rosacea reflects systemic and environmental interactions, not just a skin disorder. Key factors include environmental triggers, genetic and microbiome influences, diagnostic gaps in skin of colour and social determinants. Advances in multi‐omics and exposome integration highlight pathways towards precision medicine, prevention and equitable, patient ...
Katerina Grafanaki, Daniella Bakoli Sgourou, Alexandros Maniatis, Efstathia Pasmatzi   +3 more
wiley   +1 more source

Hepatic Steatosis and Diet in Adult Celiac Disease: A Cross-Sectional Study. [PDF]

Nutrients
Peresztegi MZ, Szakács Z, Farkas N, Szekeres G, Faluhelyi N, Hagymási K, Pásztor G, Vereczkei Z, Fülöp P, Lada S, Dakó S, Dakó E, Bajor J.   +12 more
europepmc   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

High-Quality Nutritional and Medical Care in Celiac Disease Follow-Up. [PDF]

Nutrients
Kerbage A, Jansson-Knodell C, Weekley K, Gardinier D, Rubio-Tapia A.   +4 more
europepmc   +1 more source

The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD‐ME Group

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Women with inflammatory bowel disease (IBD) and their children are at higher risk of adverse outcomes. The primary aim was to examine the association between IBD and adverse pregnancy outcomes. The secondary aim was to assess the impact of maternal IBD and medications used on children's outcomes.
Mahmoud Mosli, Nahla Azzam, Majid Almadi, Heba Alfarhan, Mansour Altuwaijiri, Abdulrahman Aljebreen, Othman Alharbi, Mohammed Abaalkhail, Maryam Jaran, Abdulaziz Altamimi, Nouf Al Turki, Lubna Alharbi, Joud A. L. Ghamdi, Amal Al Dakhil   +13 more
wiley   +1 more source

Colonic neoplasia and celiac disease: A systematic review. [PDF]

World J Gastroenterol
Khayyat YM.
europepmc   +1 more source

Microscopic colitis is associated with an increased risk of dementia in a Swedish population

Journal of Internal Medicine, EarlyView.
Abstract Background The microbiota–gut–brain axis has been implicated in dementia. Yet whether dementia is associated with microscopic colitis (MC), an age‐related inflammatory colonic disease involving gut dysbiosis, remains unknown. Methods Using the nationwide ESPRESSO cohort in Sweden, we compared MC patients histologically diagnosed 1990–2017 and ...
Xiaoying Kang, David Bergman, Jiangwei Sun, Karin Wirdefeldt, Jonas F. Ludvigsson   +4 more
wiley   +1 more source

Advances in the Prevention and Management of Celiac Disease. [PDF]

Nutrients
Nestares T, Martín-Masot R.
europepmc   +1 more source